Symbiogen Biotechnologies Private Limited
About Symbiogen Biotechnologies Private Limited
Data last updated:
Symbiogen Biotechnologies Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 09 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U02411TN2007PTC063046. Its GSTIN is 33AAKCS7846R1ZE (Tamil Nadu).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.4 Lakh. It is led by directors Neela Saravanakumar (Managing Director) and Satyamurty Gopal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.35(18) Vasudevapuram Triplicane Chennai, Tamil Nadu, India – 600005.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.83 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹28.19 Lakh (net margin 67.4%) and EBITDA of ₹28.42 Lakh (EBITDA margin 68%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 21% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Symbiogen Biotechnologies Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.35(18) Vasudevapuram Triplicane Chennai, Tamil Nadu, India – 600005
- IndustryLife Sciences, Biotechnology
To see the full contact details of Symbiogen Biotechnologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Symbiogen Biotechnologies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Symbiogen Biotechnologies Private Limited, buy the company report.
Financials of Symbiogen Biotechnologies Private Limited
FY 2025 filings availableSymbiogen Biotechnologies Private Limited reported revenue of ₹41.83 Lakh (up 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 12% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 68% | ||||
| Net Profit Margin | 67.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Symbiogen Biotechnologies Private Limited, buy the company report.
Board of directors of Symbiogen Biotechnologies Private Limited
Symbiogen Biotechnologies has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyamurty Gopal Also directs: Scigenics Biotech Private Limited | Director | 09 Apr 2007 | 19 Years 7 Months | Current |
| Neela Saravanakumar Also directs: Scigenics Biotech Private Limited | Managing Director | 09 Apr 2007 | 19 Years 7 Months | Current |
Auditor
Symbiogen Biotechnologies Private Limited is audited by SURI & SIVA for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURI & SIVA | FY 2021 | 004284S |
Shareholding
The shareholding of Symbiogen Biotechnologies Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Symbiogen Biotechnologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Symbiogen Biotechnologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Symbiogen Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Symbiogen Biotechnologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAKCS7846R1ZE | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Symbiogen Biotechnologies Private Limited, buy the company report.
Recent activity
Symbiogen Biotechnologies Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Neela Saravanakumar ceased to be Director on 10 Dec 2015.
Frequently asked questions
Symbiogen Biotechnologies is an active private limited company based in Chennai, Tamil Nadu, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 09 April 2007 (19+ years old) and is registered under CIN U02411TN2007PTC063046.
Symbiogen Biotechnologies has 2 current directors:
- Neela Saravanakumar - Managing Director
- Satyamurty Gopal - Director
The latest financial statements of Symbiogen Biotechnologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Symbiogen Biotechnologies is 33AAKCS7846R1ZE, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Symbiogen Biotechnologies is U02411TN2007PTC063046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Symbiogen Biotechnologies was incorporated on 09 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chennai.
Neela Saravanakumar ceased to be Director on 10 Dec 2015. Neela Saravanakumar was appointed as Managing Director on 09 Apr 2007. Satyamurty Gopal was appointed as Director on 09 Apr 2007.
The registered office of Symbiogen Biotechnologies is at No.3518 Vasudevapuram Triplicane Chennai, Tamil Nadu, India – 600005.
Symbiogen Biotechnologies operates in the life sciences industry, in the biotechnology segment.
The compliance status of Symbiogen Biotechnologies is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
